473.2500 -8.10 (-1.68%)
NSE Nov 20, 2026 15:31 PM
Volume: 194.0K
 

473.25
-1.68%
Karvy
Scaled up base portfolio: The company has a base portfolio in long standingGastrointestinal and Antimigraine accounting for close to 40% of existing portfolio.Operating in such long standing therapies, the company delivered Rs. 5000 Mn inrevenues in FY14 (111% YoY) and sustained the scale with 12% growth in FY15.
SMS Pharmaceuticals Ltd. is trading below its 30 day SMA of 473.6
More from SMS Pharmaceuticals Ltd.
Recommended